Loss of function of E-cadherin in embryonic stem cells and the relevance to models of tumorigenesis

Journal of Oncology

Volumn , Issue , 2011, Pages

  Ward, Christopher M ^a   Mohamet, Lisa ^a   Hawkins, Kate ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPHRIN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

APOPTOSIS; CANCER STAGING; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; EMBRYONIC STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; HUMAN; HYPOTHESIS; METASTASIS; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

EID: 79251602408     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/352616     Document Type: Review

References (119)

1. Cavallaro U., Christofori G., Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nature Reviews Cancer 2004 4 2 118 132
2. Pertz O., Bozic D., Koch A. W., Fauser C., Brancaccio A., Engel J., A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation The EMBO Journal 1999 18 7 1738 1747
3. Van Roy F., Berx G., The cell-cell adhesion molecule E-cadherin Cellular and Molecular Life Sciences 2008 65 23 3756 3788
4. Perez-Moreno M., Fuchs E., Catenins: keeping cells from getting their signals crossed Developmental Cell 2006 11 5 601 612
5. McCrea P. D., Park J.-I., Developmental functions of the P120-catenin sub-family Biochimica et Biophysica Acta-Molecular Cell Research 2007 1773 1 17 33
6. Ling K., Bairstow S. F., Carbonara C., Turbin D. A., Huntsman D. G., Anderson R. A., Type I phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with 1B adaptin Journal of Cell Biology 2007 176 3 343 353
7. Cavallaro U., Schaffhauser B., Christofori G., Cadherins and the tumour progression: is it all in a switch? Cancer Letters 2002 176 2 123 128
8. Di Croce L., Pelicci P. G., Tumour-associated hypermethylation: silencing E-cadherin expression enhances invasion and metastasis European Journal of Cancer 2003 39 4 413 414
9. Margulis A., Zhang W., Alt-Holland A., Crawford H. C., Fusenig N. E., Garlick J. A., E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs Cancer Research 2005 65 5 1783 1791
10. Cavallaro U., Christofori G., Multitasking in tumor progression: signaling functions of cell adhesion molecules Annals of the New York Academy of Sciences 2004 1014 58 66
11. Nieto M. A., The snail superfamily of zinc-finger transcription factors Nature Reviews Molecular Cell Biology 2002 3 3 155 166
12. Bols V., Peinado H., Prez-Moreno M. A., Fraga M. F., Esteller M., Cano A., The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors Journal of Cell Science 2003 116 3 499 511
13. Polette M., Nawrocki-Raby B., Gilles C., Clavel C., Birembaut P., Tumour invasion and matrix metalloproteinases Critical Reviews in Oncology/Hematology 2004 49 3 179 186
14. Nawrocki-Raby B., Gilles C., Polette M., Bruyneel E., Laronze J.-Y., Bonnet N., Foidart J.-M., Mareel M., Birembaut P., Upregulation of MMPS by soluble E-cadherin in human lung tumor cells International Journal of Cancer 2003 105 6 790 795
15. Crouch S., Spidel C. S., Lindsey J. S., HGF and ligation of v 5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering Experimental Cell Research 2004 292 2 274 287
16. Murai M., Shen X., Huang L., Carpenter W. M., Lin C. S., Silverman S., Regezi J., Kramer R. H., Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion International journal of oncology 2004 25 4 831 840
17. Khoury H., Naujokas M. A., Zuo D., Sangwan V., Frigault M. M., Petkiewicz S., Dankort D. L., Muller W. J., Park M., HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion Molecular Biology of the Cell 2005 16 2 550 561
18. Brembeck F. H., Rosrio M., Birchmeier W., Balancing cell adhesion and Wnt signaling, the key role of -catenin Current Opinion in Genetics and Development 2006 16 1 51 59
19. Watabe M., Nagafuchi A., Tsukita S., Takeichi M., Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line Journal of Cell Biology 1994 127 1 247 256
20. Doherty P., Walsh F. S., CAM-FGF receptor interactions: a model for axonal growth Molecular and Cellular Neurosciences 1996 8 2-3 99 111
21. Stenzel D., Nye E., Nisancioglu M., Adams R. H., Yamaguchi Y., Gerhardt H., Peripheral mural cell recruitment requires cell-autonomous heparan sulfate Blood 2009 114 4 915 924
22. Heasman J., Crawford A., Goldstone K., Garner-Hamrick P., Gumbiner B., McCrea P., Kintner C., Noro C. Y., Wylie C., Overexpression of cadherins and underexpression of -catenin inhibit dorsal mesoderm induction in early xenopus embryos Cell 1994 79 5 791 803
23. Bienz M., Clevers H., Linking colorectal cancer to Wnt signaling Cell 2000 103 2 311 320
24. Gottardi C. J., Gumbiner B. M., Distinct molecular forms of -catenin are targeted to adhesive or transcriptional complexes Journal of Cell Biology 2004 167 2 339 349
25. Goodwin M., Kovacs E. M., Thoreson M. A., Reynolds A. B., Yap A. S., Minimal mutation of the cytoplasmic tail inhibits the ability of E-cadherin to activate Rac but not phosphatidylinositol 3-kinase. Direct evidence of a role for cadherin-activated Rac signaling in adhesion and contact formation Journal of Biological Chemistry 2003 278 23 20533 20539
26. Thiery J. P., Cell adhesion in development: a complex signaling network Current Opinion in Genetics and Development 2003 13 4 365 371
27. Noren N. K., Niessen C. M., Gumbiner B. M., Burridge K., Cadherin engagement regulates Rho family GTPases Journal of Biological Chemistry 2001 276 36 33305 33308
28. Martin G. S., Cell signaling and cancer Cancer Cell 2003 4 3 167 174
29. Smith A. G., Embryo-derived stem cells: of mice and men Annual Review of Cell and Developmental Biology 2001 17 435 462
30. Ringe J., Kaps C., Burmester G.-R., Sittinger M., Stem cells for regenerative medicine: advances in the engineering of tissues and organs Naturwissenschaften 2002 89 8 338 351
31. Larue L., Antos C., Butz S., Huber O., Delmas V., Dominis M., Kemler R., A role for cadherins in tissue formation Development 1996 122 10 3185 3194
32. Lee J. M., Dedhar S., Kalluri R., Thompson E. W., The epithelial-mesenchymal transition: new insights in signaling, development, and disease Journal of Cell Biology 2006 172 7 973 981
33. Eastham A. M., Spencer H., Soncin F., Ritson S., Merry C. L. R., Stern P. L., Ward C. M., Epithelial-mesenchymal transition events during human embryonic stem cell differentiation Cancer Research 2007 67 23 11254 11262
34. Spencer H. L., Eastham A. M., Merry C. L. R., Southgate T. D., Perez-Campo F., Soncin F., Ritson S., Kemler R., Stern P. L., Ward C. M., E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells Molecular Biology of the Cell 2007 18 8 2838 2851
35. Ullmann U., In't Veld P., Gilles C., Sermon K., De Rycke M., Van de Velde H., Van Steirteghem A., Liebaers I., Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions Molecular Human Reproduction 2007 13 1 21 32
36. Behr R., Heneweer C., Viebahn C., Denker H.-W., Thie M., Epithelial-mesenchymal transition in colonies of rhesus monkey embryonic stem cells: a model for processes involved in gastrulation Stem Cells 2005 23 6 805 816
37. Wicki A., Lehembre F., Wick N., Hantusch B., Kerjaschki D., Christofori G., Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 2006 9 4 261 272
38. Christiansen J. J., Rajasekaran A. K., Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis Cancer Research 2006 66 17 8319 8326
39. Orsulic S., Kemler R., Expression of Eph receptors and ephrins is differentially regulated by E-cadherin Journal of Cell Science 2000 113 10 1793 1802
40. Andersen H., Mejlvang J., Mahmood S., Gromova I., Gromov P., Lukanidin E., Kriajevska M., Mellon J. K., Tulchinsky E., Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells Molecular and Cellular Biology 2005 25 20 9138 9150
41. Southall P. J., Boxer G. M., Bagshawe K. D., Hole N., Bromley M., Stern P. L., Immunohistological distribution of 5T4 antigen in normal and malignant tissues British Journal of Cancer 1990 61 1 88 95
42. Starzynska T., Wiechowska-Kozlowska A., Marlicz K., Bromley M., Roberts S. A., Lawniczak M., Kolodziej B., Zyluk A., Stern P. L., The clinical significance of 5T4 antigen in gastric carcinoma Gut 1997 41 A194
43. Starzynska T., Marsh P. J., Schofield P. F., Roberts S. A., Myers K. A., Stern P. L., Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma British Journal of Cancer 1994 69 5 899 902
44. Starzynska T., Rahi V., Stern P. L., The expression of 5T4 antigen in colorectal and gastric carcinoma British Journal of Cancer 1992 66 5 867 869
45. Starzynska T., Wiechowska-Kozlowska A., Marlicz K., Bromley M., Roberts S. A., Lawniczak M., Kolodziej B., Zyluk A., Stern P. L., 5T4 oncofetal antigen in gastric carcinoma and its clinical significance European Journal of Gastroenterology and Hepatology 1998 10 6 479 484
46. Carsberg C. J., Myers K. A., Stern P. L., Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells Molecular Biology of the Cell 1996 7 2275
47. Lindley L. E., Briegel K. J., Molecular characterization of TGF -induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells Biochemical and Biophysical Research Communications 2010 399 4 659 664
48. Sullivan N. J., Sasser A. K., Axel A. E., Vesuna F., Raman V., Ramirez N., Oberyszyn T. M., Hall B. M., Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells Oncogene 2009 28 33 2940 2947
49. Cheng H., Fukushima T., Takahashi N., Tanaka H., Kataoka H., Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases Cancer Research 2009 69 5 1828 1835
50. Yamauchi Y., Kohyama T., Takizawa H., Kamitani S., Desaki M., Takami K., Kawasaki S., Kato J., Nagase T., Tumor necrosis factor- enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor- 1 Experimental Lung Research 2010 36 1 12 24
51. Smith A. G., Heath J. K., Donaldson D. D., Wong G. G., Moreau J., Stahl M., Rogers D., Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides Nature 1988 336 6200 688 690
52. Niwa H., Ogawa K., Shimosato D., Adachi K., A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells Nature 2009 460 7251 118 122
53. Paling N. R. D., Wheadon H., Bone H. K., Welham M. J., Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling Journal of Biological Chemistry 2004 279 46 48063 48070
54. Ying Q.-L., Nichols J., Chambers I., Smith A., BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3 Cell 2003 115 3 281 292
55. Ying Q.-L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A., The ground state of embryonic stem cell self-renewal Nature 2008 453 7194 519 523
56. Soncin F., Mohamet L., Eckardt D., Ritson S., Eastham A. M., Bobola N., Russell A., Davies S., Kemler R., Merry C. L. R., Ward C. M., Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal Stem Cells 2009 27 9 2069 2080
57. Ying Q.-L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A., The ground state of embryonic stem cell self-renewal Nature 2008 453 7194 519 523
58. Chou Y.-F., Chen H.-H., Eijpe M., Yabuuchi A., Chenoweth J. G., Tesar P., Lu J., McKay R. D. G., Geijsen N., The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells Cell 2008 135 3 449 461
59. Arulanandam R., Vultur A., Cao J., Carefoot E., Elliott B. E., Truesdell P. F., Larue L., Feracci H., Raptis L., Cadherin-cadherin engagement promotes cell survival via Rac1/Cdc42 and signal transducer and activator of transcription-3 Molecular Cancer Research 2009 7 8 1310 1327
60. Massagu J., Chen Y.-G., Controlling TGF- signaling Genes and Development 2000 14 6 627 644
61. Vallier L., Mendjan S., Brown S., Ching Z., Teo A., Smithers L. E., Trotter M. W. B., Cho C.-H.-H., Martinez A., Rugg-Gunn P., Brons G., Pedersen R. A., Activin/Nodal signalling maintains pluripotency by controlling Nanog expression Development 2009 136 8 1339 1349
62. Vallier L., Alexander M., Pedersen R. A., Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells Journal of Cell Science 2005 118 19 4495 4509
63. Tesar P. J., Chenoweth J. G., Brook F. A., Davies T. J., Evans E. P., Mack D. L., Gardner R. L., McKay R. D. G., New cell lines from mouse epiblast share defining features with human embryonic stem cells Nature 2007 448 7150 196 199
64. Nagaoka M., Koshimizu U., Yuasa S., Hattori F., Chen H., Tanaka T., Okabe M., Fukuda K., Akaike T., E-cadherin-coated plates maintain pluripotent ES cells without colony formation PLoS ONE 2006 1 1, article e15
65. Shih I.-M., Herlyn M., Role of growth factors and their receptors in the development and progression of melanoma Journal of Investigative Dermatology 1993 100 2 196S 203S
66. Lzr-Molnr E., Hegyesi H., Tth S., Falus A., Autocrine and paracrine regulation by cytokines and growth factors in melanoma Cytokine 2000 12 6 547 554
67. Zwick E., Bange J., Ullrich A., Receptor tyrosine kinase signalling as a target for cancer intervention strategies Endocrine-Related Cancer 2001 8 3 161 173
68. Hubbard S. R., Miller W. T., Receptor tyrosine kinases: mechanisms of activation and signaling Current Opinion in Cell Biology 2007 19 2 117 123
69. Blume-Jensen P., Hunter T., Oncogenic kinase signalling Nature 2001 411 6835 355 365
70. Zandi R., Larsen A. B., Andersen P., Stockhausen M.-T., Poulsen H. S., Mechanisms for oncogenic activation of the epidermal growth factor receptor Cellular Signalling 2007 19 10 2013 2023
71. Plosker G. L., Keam S. J., Spotlight on trastuzumab in the management of HER2-positive metastatic and early-stage breast cancer BioDrugs 2006 20 4 259 262
72. Normanno N., Gullick W. J., Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? Endocrine-Related Cancer 2006 13 1 3 6
73. Qian X., Karpova T., Sheppard A. M., McNally J., Lowy D. R., E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases The EMBO Journal 2004 23 8 1739 1748
74. Perrais M., Chen X., Perez-Moreno M., Gumbiner B. M., E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions Molecular Biology of the Cell 2007 18 6 2013 2025
75. Andl C. D., Rustgi A. K., No one-way street: cross-talk between E-cadherin and receptor tyrosine kinase (RTK) signaling: a mechanism to regulate RTK activity Cancer Biology and Therapy 2005 4 1 28 31
76. Jeanes A., Gottardi C. J., Yap A. S., Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 2008 27 55 6920 6929
77. Seuntjens E., Umans L., Zwijsen A., Sampaolesi M., Verfaillie C. M., Huylebroeck D., Transforming Growth Factor type and Smad family signaling in stem cell function Cytokine and Growth Factor Reviews 2009 20 5-6 449 458
78. Wikstrm P., Damber J.-E., Bergh A., Role of transforming growth factor- 1 in prostate cancer Microscopy Research and Technique 2001 52 4 411 419
79. Teicher B. A., Menon K., Alvarez E., Shih P. L. C., Faul M. M., Antiangiogenic and antitumor effects of a protein kinase C inhibitor in human hepatocellular and gastric cancer xenografts In Vivo 2001 15 3 185 193 (Pubitemid 32705446)
80. Vrana J. A., Stang M. T., Grande J. P., Getz M. J., Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell- derived members of the transforming growth factor family Cancer Research 1996 56 21 5063 5070
81. Lee C., Sintich S. M., Mathews E. P., Shah A. H., Kundu S. D., Perry K. T., Cho J. S., Ilio K. Y., Cronauer M. V., Janulis L., Sensibar J. A., Transforming growth factor- in benign and malignant prostate Prostate 1999 39 4 285 290
82. Massagu J., Wotton D., Transcriptional control by the TGF- /Smad signaling system The EMBO Journal 2000 19 8 1745 1754
83. Risbridger G. P., Schmitt J. F., Robertson D. M., Activins and inhibins in endocrine and other tumors Endocrine Reviews 2001 22 6 836 858
84. Coerver K. A., Woodruff T. K., Finegold M. J., Mather J., Bradley A., Matzuk M. M., Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice Molecular Endocrinology 1996 10 5 534 543
85. Halaban R., Kwon B. S., Ghosh S., Delli Bovi P., Baird A., bFGF as an autocrine growth factor for human melanomas Oncogene Research 1988 3 2 177 186
86. Wang Y., Becker D., Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth Nature Medicine 1997 3 8 887 893
87. Huang A., Wright J. A., Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification Oncogene 1994 9 2 491 499
88. Skarda J., Fridman E., Plevova P., Hajduch M., Radova L., Ofek E., Kopolovic J., Kolek V., Kolar Z., Prognostic value of hMLH1 and hMSH2 immunohistochemical expression in non-small cell lung cancer. A tissue microarray study Biomedical papers of the Medical Faculty of the University Palack, Olomouc, Czechoslovakia 2006 150 2 255 259
89. Miyake A., Konishi M., Martin F. H., Hernday N. A., Ozaki K., Yamamoto S., Mikami T., Arakawa T., Itoh N., Structure and expression of a novel member, FGF-16, of the fibroblast growth factor family Biochemical and Biophysical Research Communications 1998 243 1 148 152 (Pubitemid 28414206)
90. Ruotsalainen T., Joensuu H., Mattson K., Salven P., High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer Cancer Epidemiology Biomarkers and Prevention 2002 11 11 1492 1495
91. Granato A. M., Nanni O., Falcini F., Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? Breast Cancer Research 2004 6 R38 R45
92. Giri D., Ropiquet F., Ittmann M., Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer Clinical Cancer Research 1999 5 5 1063 1071
93. Amit M., Carpenter M. K., Inokuma M. S., Chiu C.-P., Harris C. P., Waknitz M. A., Itskovitz-Eldor J., Thomson J. A., Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture Developmental Biology 2000 227 2 271 278
94. Allerstorfer S., Sonvilla G., Fischer H., Spiegl-Kreinecker S., Gauglhofer C., Setinek U., Czech T., Marosi C., Buchroithner J., Pichler J., Silye R., Mohr T., Holzmann K., Grasl-Kraupp B., Marian B., Grusch M., Fischer J., Micksche M., Berger W., FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities Oncogene 2008 27 30 4180 4190
95. Curtis H. J., Formal discussion of: somatic mutations and carcinogenesis Cancer Research 1965 25 8 1305 1308
96. Loeb L. A., A mutator phenotype in cancer Cancer Research 2001 61 8 3230 3239
97. Mintz B., Illmensee K., Normal genetically mosaic mice produced from malignant teratocarcinoma cells Proceedings of the National Academy of Sciences of the United States of America 1975 72 9 3585 3589
98. Rossant J., Papaioannou V. E., Outgrowth of embryonal carcinoma cells from injected blastocysts in vitro correlates with abnormal chimera development in vivo Experimental Cell Research 1985 156 1 213 220
99. Sonnenschein C., Soto A. M., Theories of carcinogenesis: an emerging perspective Seminars in Cancer Biology 2008 18 5 372 377
100. Fey C., Virchow is opposition to the therapeutic nihilismus of his times Hippokrates 1950 21 23 679 681
101. Winter K., Significance of young Rudolf Virchow in present day thinking Zeitschrift fr rztliche Fortbildung 1952 46 18 522 530
102. Gruber G. B., When Virchow was a young physician Virchows Archiv 1952 321 5 462 481
103. WAIL S. S., Mechanical and anti-evolutionary conceptions of Virchow's cellularity and progress of pathology in the Soviet Union Sovetskaia Meditsina 1950 8 6 11
104. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M. A., Dick J. E., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 1994 367 6464 645 648
105. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nature Medicine 1997 3 7 730 737
106. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 (Pubitemid 36418143)
107. Zhang P., Zuo H., Ozaki T., Nakagomi N., Kakudo K., Cancer stem cell hypothesis in thyroid cancer Pathology International 2006 56 9 485 489
108. Odoux C., Fohrer H., Hoppo T., Guzik L., Stolz D. B., Lewis D. W., Gollin S. M., Gamblin T. C., Geller D. A., Lagasse E., A stochastic model for cancer stem cell origin in metastatic colon cancer Cancer Research 2008 68 17 6932 6941
109. Clarke M. F., Dick J. E., Dirks P. B., Eaves C. J., Jamieson C. H. M., Jones D. L., Visvader J., Weissman I. L., Wahl G. M., Cancer stem cellsperspectives on current status and future directions: AACR workshop on cancer stem cells Cancer Research 2006 66 19 9339 9344
110. Kelly P. N., Dakic A., Adams J. M., Nutt S. L., Strasser A., Tumor growth need not be driven by rare cancer stem cells Science 2007 317 5836 337
111. Yoo M.-H., Hatfield D. L., The cancer stem Cell theory: is it correct? Molecules and Cells 2008 26 5 514 516
112. Mani S. A., Guo W., Liao M.-J., Eaton E. NG., Ayyanan A., Zhou A. Y., Brooks M., Reinhard F., Zhang C. C., Shipitsin M., Campbell L. L., Polyak K., Brisken C., Yang J., Weinberg R. A., The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 2008 133 4 704 715
113. Hermiston M. L., Wong M. H., Gordon J. I., Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system Genes and Development 1996 10 8 985 996
114. Libusova L., Stemmler M. P., Hierholzer A., Schwarz H., Kemler R., N-cadherin can structurally substitute for E-cadherin during intestinal development but leads to polyp formation Development 2010 137 14 2297 2305
115. Conti L., Pollard S. M., Gorba T., Reitano E., Toselli M., Biella G., Sun Y., Sanzone S., Ying Q.-L., Cattaneo E., Smith A., Niche-independent symmetrical self-renewal of a mammalian tissue stem cell PLoS Biology 2005 3 9 1594 1606
116. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H. I., Eaves C. J., Purification and unique properties of mammary epithelial stem cells Nature 2006 439 7079 993 997
117. Bryden A. A. G., Freemont A. J., Clarke N. W., George N. J. R., Paradoxical expression of E-cadherin in prostatic bone metastases BJU International 1999 84 9 1032 1034
118. Bukholm I. K., Nesland J. M., Brresen-Dale A.-L., Re-expression of E-cadherin, -catenin and -catenin, but not of -catenin, in metastatic tissue from breast cancer patients Journal of Pathology 2000 190 1 15 19
119. Gaspar R. H., De los Toyos J. R., Marcos C. A., Riera J. R., Sampedro A., Quantitative immunohistochemical analyses of the expression of E- cadherin, thrombomodulin, CD44H and CD44v6 in primary tumours of pharynx/larynx squamous cell carcinoma and their lymph node metastases Analytical Cellular Pathology 1999 18 4 183 190